Bank of America’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.34M | Sell |
254,429
-440,997
| -63% | -$5.78M | ﹤0.01% | 3634 |
|
|
2025
Q1 | $15.3M | Buy |
695,426
+646,519
| +1,322% | +$14.2M | ﹤0.01% | 2354 |
|
|
2024
Q4 | $1.31M | Sell |
48,907
-259,144
| -84% | -$6.92M | ﹤0.01% | 4047 |
|
|
2024
Q3 | $8.22M | Buy |
308,051
+35,257
| +13% | +$941K | ﹤0.01% | 2774 |
|
|
2024
Q2 | $4.91M | Buy |
272,794
+219,031
| +407% | +$3.94M | ﹤0.01% | 3119 |
|
|
2024
Q1 | $981K | Sell |
53,763
-8,505
| -14% | -$155K | ﹤0.01% | 4178 |
|
|
2023
Q4 | $681K | Buy |
62,268
+21,042
| +51% | +$230K | ﹤0.01% | 4418 |
|
|
2023
Q3 | $236K | Sell |
41,226
-11,075
| -21% | -$63.5K | ﹤0.01% | 4947 |
|
|
2023
Q2 | $405K | Sell |
52,301
-2,272
| -4% | -$17.6K | ﹤0.01% | 4614 |
|
|
2023
Q1 | $364K | Buy |
54,573
+1,993
| +4% | +$13.3K | ﹤0.01% | 4817 |
|
|
2022
Q4 | $470K | Buy |
52,580
+39,347
| +297% | +$352K | ﹤0.01% | 4730 |
|
|
2022
Q3 | $130K | Sell |
13,233
-26,685
| -67% | -$262K | ﹤0.01% | 5406 |
|
|
2022
Q2 | $318K | Buy |
39,918
+12,368
| +45% | +$98.5K | ﹤0.01% | 5032 |
|
|
2022
Q1 | $267K | Sell |
27,550
-1,236
| -4% | -$12K | ﹤0.01% | 5533 |
|
|
2021
Q4 | $440K | Buy |
28,786
+26,046
| +951% | +$398K | ﹤0.01% | 5213 |
|
|
2021
Q3 | $46K | Buy |
+2,740
| New | +$46K | ﹤0.01% | 6194 |
|